Reconstruction Method in Gastric CA Surgery Affects Bone Density

This article originally appeared here.
Share this content:
Reconstruction Method in Gastric CA Surgery Affects Bone Density
Reconstruction Method in Gastric CA Surgery Affects Bone Density

FRIDAY, Aug. 4, 2017 (HealthDay News) -- The reconstruction method may affect postoperative bone mineral density (BMD) loss in gastric cancer, according to a study published online July 31 in the Journal of Gastroenterology and Hepatology.

Taisuke Imamura, M.D., from the Kyoto Prefectural University of Medicine in Japan, and colleagues assessed 148 consecutive patients who underwent distal gastrectomy with Billroth-I (B-I) or Roux-en-Y (R-Y) reconstruction for stage I gastric cancer (2008 to 2012). BMD data were was retrospectively assessed using computed tomography attenuation values of the first lumbar vertebra after surgery.

In multivariate analysis, the researchers found that R-Y reconstruction was an independent risk factor for BMD loss after distal gastrectomy (P < 0.0001; odds ratio, 5.60). To overcome bias, propensity score-matched analysis was used, and B-I reconstruction was found to have superiority over R-Y reconstruction for preventing BMD loss in the first three years after distal gastrectomy. The cumulative hazard ratio of osteoporosis after gastrectomy was significantly higher in the R-Y group than in the B-I group (P = 0.0427).

"B-I reconstruction might be a preferable method for preventing BMD loss after gastrectomy in gastric cancer patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »